Show simple item record

dc.contributor.authorHelwa, Rehamen_US
dc.contributor.authorGansmo, Liv Beatheen_US
dc.contributor.authorRomundstad, Pål Richarden_US
dc.contributor.authorHveem, Kristianen_US
dc.contributor.authorVatten, Lars Johanen_US
dc.contributor.authorRyan, Bríd M.en_US
dc.contributor.authorHarris, Curtis C.en_US
dc.contributor.authorLønning, Per Eysteinen_US
dc.contributor.authorKnappskog, Stianen_US
dc.PublishedHelwa RHG et al. MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer. Scientific Reports. 2016;6:33153eng
dc.description.abstractTwo functional SNPs (SNP285G > C; rs117039649 and SNP309T > G; rs2279744) have previously been reported to modulate Sp1 transcription factor binding to the promoter of the proto-oncogene MDM2, and to influence cancer risk. Recently, a third SNP (SNP55C > T; rs2870820) was also reported to affect Sp1 binding and MDM2 transcription. In this large population based case-control study, we genotyped MDM2 SNP55 in 10,779 Caucasian individuals, previously genotyped for SNP309 and SNP285, including cases of colon (n = 1,524), lung (n = 1,323), breast (n = 1,709) and prostate cancer (n = 2,488) and 3,735 non-cancer controls, as well as 299 healthy African-Americans. Applying the dominant model, we found an elevated risk of colon cancer among individuals harbouring SNP55TT/CT genotypes compared to the SNP55CC genotype (OR = 1.15; 95% CI = 1.01–1.30). The risk was found to be highest for left-sided colon cancer (OR = 1.21; 95% CI = 1.00–1.45) and among females (OR = 1.32; 95% CI = 1.01–1.74). Assessing combined genotypes, we found the highest risk of colon cancer among individuals harbouring the SNP55TT or CT together with the SNP309TG genotype (OR = 1.21; 95% CI = 1.00–1.46). Supporting the conclusions from the risk estimates, we found colon cancer cases carrying the SNP55TT/CT genotypes to be diagnosed at younger age as compared to SNP55CC (p = 0.053), in particular among patients carrying the SNP309TG/TT genotypes (p = 0.009).en_US
dc.publisherNature Publishing Groupeng
dc.rightsAttribution CC BYeng
dc.titleMDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate canceren_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2016 The Author(s)
dc.source.journalScientific Reports

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY